CoChat

Asia-Pacific consensus on the management of gastro-oesophageal reflux disease: an update focusing on refractory reflux disease and Barrett's oesophagus

Open access
Fock, Kwong Ming, Talley, Nicholas, Goh, Khean Lee, Sugano, Kentaro, Katelaris, Peter, Holtmann, Gerald, Pandolfino, John E, Sharma, Prateek, Ang, Tiing Leong, Hongo, Michio, Wu, Justin, Chen, Minhu, Choi, Myung-Gyu, Law, Ngai Moh, Sheu, Bor-Shyang, Zhang, Jun, Ho, Khek Yu, Sollano, Jose, Rani, Abdul Aziz, Kositchaiwat, Chomsri, Bhatia, Shobna · 2016 · Gut
Cited by 194

The DOI matches its Crossref record; 4 of the 4 references it cites were found in a registry or an index.

Abstract

Objective: Since the publication of the Asia-Pacific consensus on gastro-oesophageal reflux disease in 2008, there has been further scientific advancement in this field. This updated consensus focuses on proton pump inhibitor-refractory reflux disease and Barrett's oesophagus. Methods: A steering committee identified three areas to address: (1) burden of disease and diagnosis of reflux disease; (2) proton pump inhibitor-refractory reflux disease; (3) Barrett's oesophagus. Three working groups formulated draft statements with supporting evidence. Discussions were done via email before a final face-to-face discussion. We used a Delphi consensus process, with a 70% agreement threshold, using Grading of Recommendations Assessment, Development and Evaluation (GRADE) criteria to categorise the quality of evidence and strength of recommendations. Results: A total of 32 statements were proposed and 31 were accepted by consensus. A rise in the prevalence rates of gastro-oesophageal reflux disease in Asia was noted, with the majority being non-erosive reflux disease. Overweight and obesity contributed to the rise. Proton pump inhibitor-refractory reflux disease was recognised to be common. A distinction was made between refractory symptoms and refractory reflux disease, with clarification of the roles of endoscopy and functional testing summarised in two algorithms. The definition of Barrett's oesophagus was revised such that a minimum length of 1 cm was required and the presence of intestinal metaplasia no longer necessary. We recommended the use of standardised endoscopic reporting and advocated endoscopic therapy for confirmed dysplasia and early cancer. Conclusions: These guidelines standardise the management of patients with refractory gastro-oesophageal reflux disease and Barrett's oesophagus in the Asia-Pacific region.

Overview

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.1136/gutjnl-2016-311715

Cites

4 of 4 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cites

Show all 4 references

Cited by

See all 194

Metadata

Authors
Fock, K. M., Talley, N., Goh, K. L., Sugano, K., Katelaris, P., Holtmann, G., Pandolfino, J. E., Sharma, P., Ang, T. L., Hongo, M., Wu, J., Chen, M., Choi, M.-G., Law, N. M., Sheu, B.-S., Zhang, J., Ho, K. Y., Sollano, J., Rani, A. A., Kositchaiwat, C., & Bhatia, S.
Venue
Gut
Publisher
BMJ
Published
2016-06-03
Volume
65
Issue
9
Pages
1402-1415
ISSN
  • 0017-5749 (ISSN-L)
  • 1468-3288
OpenAlex
W2417894215
Cited by
194
References
4
FWCI
14.09
Type
journal article
Language
en
Open access
bronze

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

How to cite

Cite CoChat for the checks on this page, and the paper for its own findings.

This page
CoChat. (2026). Citation check: Asia-Pacific consensus on the management of gastro-oesophageal reflux disease: an update focusing on refractory reflux disease and Barrett's oesophagus. https://app.cochat.ai/papers/10.1136/gutjnl-2016-311715
The paper
Fock, K. M., Talley, N., Goh, K. L., Sugano, K., Katelaris, P., Holtmann, G., Pandolfino, J. E., Sharma, P., Ang, T. L., Hongo, M., Wu, J., Chen, M., Choi, M.-G., Law, N. M., Sheu, B.-S., Zhang, J., Ho, K. Y., Sollano, J., Rani, A. A., . . . Bhatia, S. (2016). Asia-Pacific consensus on the management of gastro-oesophageal reflux disease: an update focusing on refractory reflux disease and Barrett's oesophagus. Gut. https://doi.org/10.1136/gutjnl-2016-311715

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.